$0.00

+0.00 (+0.00%)

OTC · Healthcare · Biotechnology · Tech Score Sell · Power 43 · $2310 mcap · 4M float · 1.25% daily turnover · Short 71% of daily vol

Overview News Chart Smart Money Financials Income Statement Cash Flow Balance Sheet Earnings

Dividends Analysis Technicals Weather Peers ESG Institutions Dark Pool Short Interest Supply Chain

Analyst Insights

Wall Street analyst consensus based on price targets and buy/sell/hold recommendations from institutional research coverage over the trailing 12 months.

Analyst Price Targets

Analyst Recommendations

Rating Summary

Price Target Change History

Date	Firm	Analyst	Old	New	Change	Upside @ Call	Stock@Call
2024-04-09	Maxim Group	Jason McCarthy	Initiated	$2	—	+183.9%	$0.70

Financial Rating

Composite financial health rating (A+ to F) based on discounted cash flow valuation, return on equity, return on assets, debt-to-equity leverage, and relative P/E and P/B multiples.

Sep 29, 2026

DCF

ROE

ROA

D/E

P/E

P/B

The Financial Rating evaluates six fundamental factors — discounted cash flow (DCF) valuation, return on equity (ROE), return on assets (ROA), debt-to-equity leverage (D/E), and relative price-to-earnings (P/E) and price-to-book (P/B) multiples — each scored 1–5. LIPO receives an overall rating of C. Areas of concern: DCF (1/5), ROE (1/5), ROA (1/5), P/E (1/5).

Rating Change History

Date	From	To
2026-09-29	None	ADDED
2026-09-29	EXISTED	None
2026-09-23	None	ADDED
2026-09-23	EXISTED	None
2026-09-09	None	ADDED
2026-09-07	EXISTED	None
2026-09-01	None	ADDED
2026-08-30	EXISTED	None
2026-08-17	None	ADDED
2026-08-16	EXISTED	None

InsiderStreet Scorecard

Proprietary multi-factor scorecard rating companies across seven fundamental dimensions — profitability, balance sheet strength, earnings quality, growth, value, momentum, and safety — each scored 0–100.

★ ★ ★ ★ ★ — Grade A+

Profitability

—

Balance Sheet

Earnings Quality

Growth

Value

Momentum

Safety

Cash Flow

Risk & Quality Signals

Academic financial models used by institutional investors to assess bankruptcy risk, earnings manipulation, financial strength, and credit quality.

Altman Z-Score

-16.30

Distress Zone

Piotroski F-Score

1/9

✗ ✗ ✗ ✗ ✗ ✓ ✗ ✗ ✗

Beneish M-Score

—

Ohlson O-Score

5012.17

Bankruptcy prob: 100.0%

High Risk

Credit Rating

Score: 44.2/100

Trend: Stable

Earnings Quality

—

OCF/NI: 443.10x

Accruals: 104493.4%

The Altman Z-Score (1968) combines five ratios — working capital, retained earnings, EBIT, market value of equity, and sales, all relative to total assets or liabilities — into a single bankruptcy predictor. LIPO scores -16.30, placing it in the Distress Zone (safe > 2.99, distress < 1.81). Historically, companies in this range face elevated bankruptcy risk. The Piotroski F-Score (2000) is a 9-point binary checklist — four profitability tests (positive ROA, positive cash flow, improving ROA, cash flow exceeding net income), three leverage tests (declining debt ratio, improving current ratio, no share dilution), and two efficiency tests (improving gross margin, improving asset turnover). Each pass scores 1 point. LIPO scores 1/9, suggesting weak financial fundamentals — the company fails the majority of these accounting tests. The Ohlson O-Score (1980) is a 9-variable logistic regression that estimates bankruptcy probability using firm size, leverage, working capital, current ratio, profitability (ROA), cash flow coverage, negative equity flag, consecutive losses flag, and earnings trajectory. The raw score is converted to a probability via logistic transformation. LIPO's implied 100.0% bankruptcy probability signals significant financial distress. Our Credit Rating model scores companies on five weighted components — solvency (30%), earning power (25%), leverage (20%), liquidity (15%), and cash flow quality (10%) — then blends the absolute score with sector and industry peer rankings. For companies with large buyback programs, equity is adjusted by adding back cumulative 5-year repurchases (capped at 80% of FCF generated) to avoid penalizing shareholder-friendly capital allocation. LIPO receives an estimated rating of BB (score: 44.2/100), with a stable trend.

Valuation

Key valuation multiples comparing the stock's market price to its earnings, revenue, book value, and cash flows. Lower multiples may indicate relative undervaluation versus peers.

P/E

-0.00x

PEG

-0.00x

P/S

0.00x

P/B

0.00x

P/FCF

-0.00x

P/OCF

—

EV/EBITDA

-0.21x

EV/Revenue

6.55x

EV/EBIT

-0.21x

EV/FCF

-0.00x

Earnings Yield

-195.27%

FCF Yield

-86522.65%

Shareholder Yield

0.00%

Graham Number

—

Equity-based multiples (P/E, P/B, P/FCF) compare the stock price to per-share fundamentals and are affected by capital structure. Enterprise value multiples (EV/EBITDA, EV/Revenue, EV/FCF) strip out debt and cash, making them more useful for cross-company comparisons regardless of how companies are financed. The Graham Number — √(22.5 × EPS × Book Value) — is Benjamin Graham's formula for the maximum price a defensive investor should pay. LIPO currently has negative earnings — the P/E ratio is not meaningful.

DuPont Decomposition (5-Factor)

The 5-factor DuPont framework breaks Return on Equity into its component drivers — tax efficiency, interest burden, operating profitability, asset utilization, and financial leverage — to reveal what truly drives shareholder returns.

Tax Burden

1.000

NI / EBT

Interest Burden

0.991

EBT / EBIT

EBIT Margin

-30.973

EBIT / Rev

Asset Turnover

0.077

Rev / Assets

Equity Multiplier

1.531

Assets / Equity

ROE

-361.8%

The 5-factor DuPont identity decomposes ROE as: Tax Burden × Interest Burden × EBIT Margin × Asset Turnover × Equity Multiplier = ROE. This reveals whether returns are driven by operating performance, financial leverage, or tax efficiency — three very different sources of profitability. LIPO's ROE of -361.8% is driven by Asset Turnover (0.077), indicating efficient use of assets to generate revenue. A tax burden ratio of 1.00 indicates minimal tax leakage — the company retains over 90% of pre-tax earnings.

Graham-Dodd Adjusted Valuation

Our adaptation of Graham's growth formula (Fair P/E = 8.5 + 2g) from The Intelligent Investor. The classic version relies on analyst growth projections, which can be unreliable. This adjusted model substitutes the company's realized 3-year EPS CAGR — a backward-looking, verifiable measure of actual earnings power — grounding the valuation in demonstrated performance rather than forecasts.

Two adjustments we make, and why. Growth is capped at 15%. Graham defined g as expected growth over the next seven to ten years, not last year's rate. Across US companies since 1994 the median realized 7-year EPS growth is 5–8% regardless of how fast a company grew beforehand, and of 4,457 company-quarters that grew faster than 200%, none sustained it. Uncapped, the formula assigned fair multiples in the hundreds to companies that had never held that rate — and scored worse than simply reading the P/E. Capped, it carries real information. The verdict has three states, not two. Tested over 377,249 stock-months, this ratio only separates outcomes at its extremes: below 0.25 beat the universe by 1.3 points a year, above 3.0 lagged by 2.7, and everything in between sat inside a one-point band. Rather than call two-thirds of the market "undervalued" on a threshold of 1.0, we say Neutral where the model cannot tell — which is most of the time.

Adj. Growth Rate

0.00%

Fair P/E

8.50x

Intrinsic Value

—

Price/Value

—

Margin of Safety

—

Premium

—

Profitability Trends

Historical profitability ratios tracking how efficiently the company converts revenue into returns for shareholders over time.

Leverage & Solvency Trends

Debt and liquidity metrics showing the company's financial leverage and ability to meet short-term and long-term obligations.

Efficiency & Working Capital Trends

Operating efficiency metrics measuring how quickly the company converts inventory to sales, collects receivables, and manages its cash conversion cycle.

Growth Trends (YoY %)

Year-over-year growth rates for key financial metrics, showing the trajectory of revenue, earnings, and cash flow generation.

Earnings Stability

R-squared of linear regression measuring how predictably revenue, earnings, and margins follow a trend over the trailing 5 years. 1.0 = perfectly predictable; lower values indicate erratic or cyclical behavior.

Monte Carlo Price Simulation

Geometric Brownian Motion with 1,000 antithetic paths over 1 year, seeded from 950 days of historical volatility. Percentile bands show the range of statistically plausible outcomes — this is a statistical model, not a forecast.

Current Price

$0.00

Median 1Y

$0.00

5th Pctile

$0.00

95th Pctile

$0.00

Ann. Volatility

475.9%

25th–75th percentile 5th–95th percentile Median path Historical

Executive Compensation

C-suite compensation breakdown including salary, stock awards, options, and incentive pay. The CEO-to-employee pay ratio and Gini coefficient measure pay distribution fairness.

C-Suite Compensation

Executive	Salary	Stock	Total
Jonathan Kaufman, Chief Executive Officer	$204,133	$—	$323,383
Michael Chancellor, Medical edical Officer	$195,833	$—	$315,083
Douglas Johnston, Financial ancial Officer	$165,000	$—	$260,000

CEO Pay Ratio

1:1

CEO-to-Employee Pay Ratio

CEO Total Comp: $323,383

Avg Employee Cost (SGA/emp): $400,742

Employees: 5

C-Suite Pay Equality (Gini)

CEO Compensation Mix

Workforce & Productivity

Workforce efficiency metrics measuring revenue, profit, and R&D spend per employee — key indicators of operational leverage and human capital productivity.

Employees

0.0% YoY

Revenue / Employee

$107,271

Rev: $536,357

Profit / Employee

$-1,003,253

NI: $-5,016,264

SGA / Employee

$400,742

Avg labor cost proxy

Scaling Efficiency

All Ratios & Metrics

Complete fundamental data with up to 20 periods of history, sparkline trends, and current values across 13 categories and 130+ financial metrics.

Profitability

Metric	Q4'22	Q1'23	Q2'23	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Current
ROE	-7.8%	-37.5%	-95.0%	-1.9%	-1.2%	-1.5%	-1.7%	-2.3%	-2.0%	-1.5%	-2.5%	-3.6%	-3.62%
ROA	-6.1%	-31.0%	-85.1%	-1.5%	-97.0%	-1.2%	-1.5%	-1.7%	-1.6%	-1.3%	-1.9%	-2.4%	-2.36%
ROIC	17.1%	-6.1%	-17.3%	113.9%	295.3%	-6.7%	-5.5%	-19.6%	18.4%	33.7%	-10.2%	41.1%	41.06%
ROCE	-7.5%	-36.5%	-93.9%	-1.9%	-1.5%	-1.8%	-2.4%	-2.9%	-2.6%	-1.3%	-1.9%	-3.2%	-3.15%
Gross Margin	-2.2%	—	-8.9%	-7.0%	99.4%	100.0%	99.0%	-12.0%	-5.1%	—	—	—	—
Operating Margin	-2.4%	—	-14.8%	-13.0%	-6.0%	-8.3%	-7.0%	-18.2%	-8.4%	—	—	—	—
Net Margin	-2.4%	—	-14.4%	-12.7%	-5.7%	-8.2%	-6.9%	-18.0%	-8.3%	—	—	—	—
EBITDA Margin	-2.4%	—	0.0%	-12.7%	-5.7%	-8.2%	-6.9%	-18.0%	-8.3%	—	—	—	—
FCF Margin	-1.5%	-8.7%	-7.6%	-7.4%	-9.5%	-7.3%	-7.4%	-7.6%	-7.4%	-10.2%	-17.7%	-13598.6%	-13598.58%
OCF Margin	-1.5%	-8.7%	-7.6%	-7.3%	-9.5%	-7.2%	-7.3%	-7.6%	-7.4%	-10.2%	-17.7%	-13598.6%	-13598.58%
ROE 3Y Avg	snapshot only												-2.81%
ROA 3Y Avg	snapshot only												-1.92%
ROIC Economic	snapshot only												-2.44%
Cash ROA	snapshot only												-1005.02%
NOPAT Margin	snapshot only												-24.61%
Pretax Margin	snapshot only												-30.69%
R&D / Revenue	snapshot only												6.12%
SGA / Revenue	snapshot only												12.85%
SBC / Revenue	snapshot only												46.45%

Valuation

Metric	Q4'22	Q1'23	Q2'23	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Current
P/E Ratio	-37.85	-7.82	-4.14	-2.01	-1.50	-1.05	-0.83	-0.99	-0.64	-0.51	-0.68	-0.51	-0.000
P/S Ratio	91.22	74.17	47.70	23.86	20.83	10.46	6.75	8.75	5.96	6.74	14.71	15.72	0.000
P/B Ratio	2.95	2.93	3.93	3.88	2.20	1.95	2.01	2.90	1.67	0.64	1.36	1.83	0.002
P/FCF	-59.49	-8.55	-6.26	-3.23	-2.18	-1.44	-0.92	-1.15	-0.81	-0.66	-0.83	-0.00	-0.001
P/OCF	—	—	—	—	—	—	—	—	—	—	—	—	—
EV/EBITDA	-25.28	-5.41	-6.65	-2.34	-1.23	-0.94	-0.56	-0.69	-0.21	0.31	-7.96	-0.21	-0.212
EV/Revenue	60.14	50.15	36.11	17.63	11.31	6.30	4.59	6.10	1.98	-4.02	173.72	6.55	6.552
EV/EBIT	-25.28	-5.33	-3.10	-1.48	-0.81	-0.63	-0.56	-0.69	-0.21	0.31	-7.95	-0.21	-0.212
EV/FCF	-39.22	-5.78	-4.74	-2.39	-1.18	-0.86	-0.62	-0.80	-0.27	0.39	-9.80	-0.00	-0.000
Earnings Yield	-2.6%	-12.8%	-24.2%	-49.8%	-66.9%	-94.9%	-1.2%	-1.0%	-1.6%	-2.0%	-1.5%	-2.0%	-1.95%
FCF Yield	-1.7%	-11.7%	-16.0%	-30.9%	-45.8%	-69.6%	-1.1%	-87.2%	-1.2%	-1.5%	-1.2%	-865.2%	-865.23%
Price/Tangible Book	snapshot only												1.835
Shareholder Yield	snapshot only												0.00%

Leverage & Solvency

Metric	Q4'22	Q1'23	Q2'23	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Current
Current Ratio	4.92	6.24	11.27	4.87	8.90	5.46	4.33	2.97	3.47	6.21	4.60	3.24	3.237
Quick Ratio	4.92	6.24	11.27	4.87	8.90	5.46	4.33	2.97	3.47	6.21	4.60	3.24	3.237
Debt/Equity	0.09	0.10	0.04	0.07	0.04	0.05	0.05	0.05	0.02	0.01	15.75	0.18	0.178
Net Debt/Equity	-1.00	-0.95	-0.96	-1.01	-1.00	-0.78	-0.64	-0.88	-1.11	-1.03	14.73	-1.07	-1.070
Debt/Assets	0.07	0.08	0.04	0.06	0.04	0.04	0.04	0.03	0.02	0.00	11.61	0.11	0.112
Debt/EBITDA	-1.20	-0.28	-0.09	-0.06	-0.04	-0.04	-0.02	-0.02	-0.01	-0.00	-7.78	-0.05	-0.049
Net Debt/EBITDA	13.06	2.59	2.13	0.83	1.03	0.62	0.26	0.30	0.43	0.82	-7.28	0.30	0.296
Interest Coverage	-76.37	-140.79	-192.70	-277.80	-428.66	-876.32	—	—	—	—	—	—	—
Equity Multiplier	1.27	1.21	1.12	1.28	1.14	1.22	1.28	1.48	1.39	1.19	1.36	1.58	1.580
Cash Ratio	snapshot only												2.889
Cash to Debt	snapshot only												7.027
FCF to Debt	snapshot only												-8942.687
Defensive Interval	snapshot only												336.1 days

Efficiency & Turnover

Metric	Q4'22	Q1'23	Q2'23	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Current
Asset Turnover	0.03	0.03	0.07	0.13	0.07	0.12	0.18	0.19	0.17	0.10	0.09	0.08	0.077
Inventory Turnover	—	—	—	—	—	—	—	—	—	—	—	—	—
Receivables Turnover	1.33	1.80	9.19	6.81	4.54	6.25	16.01	11.48	9.17	5.05	6.57	11.18	11.176
Payables Turnover	1.24	7.87	101.08	10.11	9.90	8.55	8.34	2.75	8.02	9.05	9.90	7.74	7.738
DSO	275	203	40	54	80	58	23	32	40	72	56	33	32.7 days
DIO	0	0	0	0	0	0	0	0	0	0	0	0	0.0 days
DPO	293	46	4	36	37	43	44	133	46	40	37	47	47.2 days
Cash Conversion Cycle	-19	157	36	18	43	16	-21	-101	-6	32	19	-15	-14.5 days
Fixed Asset Turnover	snapshot only												0.642
Cash Velocity	snapshot only												0.094
Capital Intensity	snapshot only												13.531

Growth (YoY)

Metric	Q4'22	Q1'23	Q2'23	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Current
Revenue	—	—	—	—	1.2%	2.2%	96.8%	33.7%	61.8%	-18.2%	-49.9%	-64.1%	-64.08%
Net Income	—	—	—	—	-11.7%	-2.3%	-39.5%	0.7%	-8.6%	-8.2%	-33.3%	-25.0%	-25.01%
EPS	—	—	—	—	-7.2%	-1.6%	-5.3%	36.2%	12.3%	5.9%	70.6%	69.2%	69.25%
FCF	—	—	—	—	-12.7%	-1.7%	-90.3%	-38.2%	-24.8%	-14.8%	-20.4%	-639.3%	-639.34%
EBITDA	—	—	—	—	-7.5%	-1.3%	-2.0%	-56.5%	-64.3%	-60.1%	-34.0%	-26.2%	-26.18%
Op. Income	—	—	—	—	-12.2%	-2.4%	-41.0%	0.4%	-7.1%	-6.4%	-31.5%	-24.1%	-24.11%
OCF Growth	snapshot only												-639.34%
Asset Growth	snapshot only												8.78%
Equity Growth	snapshot only												1.97%
Debt Growth	snapshot only												2.73%
Shares Change	snapshot only												3.06%

Growth Quality

Metric	Q4'22	Q1'23	Q2'23	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Current
Revenue Stability	—	—	—	—	—	—	—	—	1.00	0.50	0.00	0.36	0.363
Earnings Stability	—	—	—	—	—	—	—	—	0.81	0.83	1.00	0.73	0.728
Margin Stability	—	—	—	—	—	—	—	—	0.37	0.60	0.09	0.01	0.006
Rev. Growth Consistency	0.00	0.00	0.00	0.00	0.50	0.50	0.50	0.50	1.00	0.00	0.00	0.00	0.000
Earn. Growth Consistency	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.50	0.00	0.00	0.00	0.00	0.000
FCF Positive Streak	0	0	0	0	0	0	0	0	0	0	0	0	0
Earnings Persistence	—	—	—	—	—	—	—	—	0.97	0.97	0.87	0.90	0.900
Earnings Smoothness	—	—	—	—	—	—	—	—	—	—	—	—	—
ROE Trend	—	—	—	—	—	—	—	—	-1.84	-0.14	-0.32	-1.16	-1.155
Gross Margin Trend	—	—	—	—	—	—	—	—	1.55	-2.09	-10.18	-15.23	-15.229
FCF Margin Trend	—	—	—	—	—	—	—	—	-1.83	-2.24	-10.23	-13591.08	-13591.081
Sustainable Growth Rate	—	—	—	—	—	—	—	—	—	—	—	—	—
Internal Growth Rate	—	—	—	—	—	—	—	—	—	—	—	—	—

Cash Flow Quality

Metric	Q4'22	Q1'23	Q2'23	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Current
OCF/Net Income	0.64	0.91	0.66	0.62	0.68	0.73	0.90	0.87	0.79	0.78	0.82	443.10	443.099
FCF/OCF	1.00	1.00	1.00	1.01	1.00	1.00	1.00	1.00	1.00	1.00	1.00	1.00	1.000
FCF/Net Income	snapshot only												443.099
CapEx/Revenue	0.0%	0.0%	0.0%	4.0%	4.4%	3.0%	2.8%	0.0%	0.0%	0.0%	0.0%	0.0%	0.00%
CapEx/Depreciation	snapshot only												0.000
Accruals Ratio	-0.02	-0.03	-0.29	-0.58	-0.31	-0.33	-0.15	-0.23	-0.34	-0.29	-0.34	1044.93	1044.934
Sloan Accruals	snapshot only												0.024

Dividends & Buybacks

Metric	Q4'22	Q1'23	Q2'23	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Current
Dividend Yield	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.00%
Dividend/Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Payout Ratio	—	—	—	—	—	—	—	—	—	—	—	—	—
FCF Payout Ratio	—	—	—	—	—	—	—	—	—	—	—	—	—
Total Payout Ratio	—	—	—	—	—	—	—	—	—	—	—	—	—
Div. Increase Streak	—	—	—	—	—	—	—	—	—	—	—	—	—
Chowder Number	—	—	—	—	—	—	—	—	—	—	—	—	—
Buyback Yield	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.00%
Net Buyback Yield	-36.0%	-44.3%	-40.4%	-57.5%	0.0%	-4.0%	-5.8%	-24.1%	-31.9%	-1.6%	-1.1%	-2.5%	-2.53%
Total Shareholder Return	-36.0%	-44.3%	-40.4%	-57.5%	0.0%	-4.0%	-5.8%	-24.1%	-31.9%	-1.6%	-1.1%	-2.5%	-2.53%

DuPont Factors

Metric	Q4'22	Q1'23	Q2'23	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Current
Tax Burden (NI/EBT)	1.00	1.00	1.00	1.00	1.00	1.00	1.00	1.00	1.00	1.00	1.00	1.00	1.000
Interest Burden (EBT/EBIT)	1.01	1.01	0.99	0.99	0.99	0.99	1.00	1.00	1.00	1.00	0.99	0.99	0.991
EBIT Margin	-2.38	-9.41	-11.63	-11.94	-14.02	-10.01	-8.17	-8.82	-9.35	-13.14	-21.84	-30.97	-30.973
Asset Turnover	0.03	0.03	0.07	0.13	0.07	0.12	0.18	0.19	0.17	0.10	0.09	0.08	0.077
Equity Multiplier	1.27	1.21	1.12	1.28	1.22	1.22	1.17	1.36	1.23	1.20	1.33	1.53	1.531

Per Share

Metric	Q4'22	Q1'23	Q2'23	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Current
EPS (Diluted TTM)	$-0.66	$-1.99	$-4.14	$-5.97	$-5.46	$-5.20	$-4.36	$-3.81	$-4.79	$-4.90	$-1.28	$-1.17	$-1.17
Book Value/Share	$8.50	$5.32	$4.35	$3.09	$3.72	$2.81	$1.79	$1.30	$1.83	$3.89	$0.64	$0.33	$0.33
Tangible Book/Share	$8.50	$5.32	$4.35	$3.09	$3.72	$2.81	$1.79	$1.30	$1.83	$3.89	$0.64	$0.33	$0.33
Revenue/Share	$0.27	$0.21	$0.36	$0.50	$0.39	$0.52	$0.53	$0.43	$0.51	$0.37	$0.06	$0.04	$0.00
FCF/Share	$-0.42	$-1.82	$-2.74	$-3.71	$-3.74	$-3.81	$-3.93	$-3.30	$-3.77	$-3.81	$-1.05	$-519.14	$-518.92
OCF/Share	$-0.42	$-1.82	$-2.74	$-3.69	$-3.72	$-3.80	$-3.92	$-3.30	$-3.77	$-3.81	$-1.05	$-519.14	$-518.92
Cash/Share	$9.31	$5.60	$4.34	$3.35	$3.89	$2.31	$1.25	$1.21	$2.08	$4.03	$0.65	$0.41	$0.41
EBITDA/Share	$-0.65	$-1.95	$-1.95	$-3.79	$-3.61	$-3.51	$-4.35	$-3.81	$-4.78	$-4.89	$-1.29	$-1.18	$-1.18
Debt/Share	$0.78	$0.54	$0.18	$0.22	$0.16	$0.13	$0.10	$0.06	$0.05	$0.02	$10.03	$0.06	$0.06
Net Debt/Share	$-8.53	$-5.05	$-4.16	$-3.13	$-3.73	$-2.18	$-1.15	$-1.15	$-2.04	$-4.01	$9.38	$-0.35	$-0.35

Academic Models

Metric	Q4'22	Q1'23	Q2'23	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Current
Altman Z-Score	—	—	—	—	—	—	—	—	—	—	—	—	-16.303
Altman Z-Prime	snapshot only												-34.724
Piotroski F-Score	2	2	2	2	5	3	3	3	3	4	3	1	1
Beneish M-Score	—	—	—	—	-9.54	—	-8.54	-4.48	-3.93	—	—	—	—
Ohlson O-Score	snapshot only												5012.169
ROIC (Greenblatt)	snapshot only												-3.15%
Net-Net WC	snapshot only												$0.27

Credit

Metric	Q4'22	Q1'23	Q2'23	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Current
Credit Rating	snapshot only												BB
Credit Score	65.57	64.83	65.15	33.54	50.31	33.54	44.23	43.93	44.10	44.12	34.77	44.18	44.179
Credit Grade	snapshot only												12
Credit Trend	snapshot only												0.254
Implied Spread (bps)	snapshot only												475.000
Industry Credit Rank	snapshot only												42
Sector Credit Rank	snapshot only												35

LIPO OTC

Analyst Insights

Financial Rating

InsiderStreet Scorecard

Risk & Quality Signals

Valuation

DuPont Decomposition (5-Factor)

Graham-Dodd Adjusted Valuation

Profitability Trends

Leverage & Solvency Trends

Efficiency & Working Capital Trends

Growth Trends (YoY %)

Earnings Stability

Monte Carlo Price Simulation

Executive Compensation

C-Suite Compensation

CEO Pay Ratio

C-Suite Pay Equality (Gini)

CEO Compensation Mix

Workforce & Productivity

Scaling Efficiency

Sign in to InsiderStreet